Labcorp Holdings LH Diagnostics — Operating Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Labcorp Holdings in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Labcorp Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Labcorp Holdings's diagnostics — operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Labcorp Holdings's diagnostics — operating income?
- Labcorp Holdings (LH) reported diagnostics — operating income of $458.7M in Q1 2026.
- How has Labcorp Holdings's diagnostics — operating income changed year-over-year?
- Labcorp Holdings's diagnostics — operating income increased by 7.3% year-over-year, from $427.5M to $458.7M.
- What is the long-term trend for Labcorp Holdings's diagnostics — operating income?
- Over 4 years (2021 to 2025), Labcorp Holdings's diagnostics — operating income has grown at a -13.7% compound annual growth rate (CAGR), from $3.21B to $1.78B.
- What does diagnostics — operating income mean?
- This metric represents the profitability of the core laboratory testing and diagnostic services segment after accounting for direct operating costs, including labor, medical supplies, and depreciation. It serves as a primary indicator of the segment's ability to generate earnings from its clinical testing operations before interest, taxes, and corporate-level overhead. This measure reflects the operational efficiency and pricing power of the diagnostic business unit.